DE69705877D1 - Verwendung von Anionenaustauscherharzen zur Herstellung eines Arzneimittels zur Behandlung der Hyperphosphatemie - Google Patents

Verwendung von Anionenaustauscherharzen zur Herstellung eines Arzneimittels zur Behandlung der Hyperphosphatemie

Info

Publication number
DE69705877D1
DE69705877D1 DE69705877T DE69705877T DE69705877D1 DE 69705877 D1 DE69705877 D1 DE 69705877D1 DE 69705877 T DE69705877 T DE 69705877T DE 69705877 T DE69705877 T DE 69705877T DE 69705877 D1 DE69705877 D1 DE 69705877D1
Authority
DE
Germany
Prior art keywords
hyperphosphatemia
medicament
manufacture
treatment
anion exchange
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69705877T
Other languages
English (en)
Other versions
DE69705877T2 (de
Inventor
Masayuki Matsuka
Hiroshi Shimada
Mizue Kawai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Chemical Corp
Original Assignee
Mitsubishi Chemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Chemical Corp filed Critical Mitsubishi Chemical Corp
Application granted granted Critical
Publication of DE69705877D1 publication Critical patent/DE69705877D1/de
Publication of DE69705877T2 publication Critical patent/DE69705877T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE69705877T 1996-03-05 1997-03-04 Verwendung von Anionenaustauscherharzen zur Herstellung eines Arzneimittels zur Behandlung der Hyperphosphatemie Expired - Lifetime DE69705877T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4776596 1996-03-05

Publications (2)

Publication Number Publication Date
DE69705877D1 true DE69705877D1 (de) 2001-09-06
DE69705877T2 DE69705877T2 (de) 2002-06-06

Family

ID=12784473

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69705877T Expired - Lifetime DE69705877T2 (de) 1996-03-05 1997-03-04 Verwendung von Anionenaustauscherharzen zur Herstellung eines Arzneimittels zur Behandlung der Hyperphosphatemie

Country Status (8)

Country Link
US (1) US5980881A (de)
EP (1) EP0793960B1 (de)
KR (1) KR100561784B1 (de)
CN (1) CN1080121C (de)
CA (1) CA2199194C (de)
DE (1) DE69705877T2 (de)
ES (1) ES2162658T3 (de)
TW (1) TW528597B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0922461A4 (de) * 1996-07-19 2002-07-17 Nikken Chemicals Co Ltd Heilmittel gegen hyperphosphatanämie
US6726905B1 (en) 1997-11-05 2004-04-27 Genzyme Corporation Poly (diallylamines)-based phosphate binders
WO2001066607A1 (fr) * 2000-03-09 2001-09-13 Hisamitsu Pharmaceutical Co., Inc. Resine echangeuse d'anions reticulee ou sel de celle-ci et adsorbant phosphoreux la contenant
US20040059065A1 (en) * 2000-03-09 2004-03-25 Takeshi Goto Crosslinked anion-exchange resin or salt thereof
US20030091530A1 (en) * 2000-03-13 2003-05-15 Takeshi Goto Preventives and/or remedies for hyperphosphatemia
US8173114B2 (en) * 2000-11-28 2012-05-08 Mitsubishi Tanabe Pharma Corporation Excretion accelerator for accumulative chlorine compound
AU2001292368A1 (en) * 2000-11-28 2002-06-11 Mitsubishi Pharma Corporation Antiobestic agents and health foods
JP4353414B2 (ja) 2001-07-30 2009-10-28 田辺三菱製薬株式会社 食後過血糖改善剤
US7335795B2 (en) 2004-03-22 2008-02-26 Ilypsa, Inc. Crosslinked amine polymers
US7608674B2 (en) 2003-11-03 2009-10-27 Ilypsa, Inc. Pharmaceutical compositions comprising cross-linked small molecule amine polymers
US7385012B2 (en) 2003-11-03 2008-06-10 Ilypsa, Inc. Polyamine polymers
US7449605B2 (en) 2003-11-03 2008-11-11 Ilypsa, Inc. Crosslinked amine polymers
US7767768B2 (en) 2003-11-03 2010-08-03 Ilypsa, Inc. Crosslinked amine polymers
US7459502B2 (en) 2003-11-03 2008-12-02 Ilypsa, Inc. Pharmaceutical compositions comprising crosslinked polyamine polymers
DE112005000708B4 (de) 2004-03-30 2017-12-21 Relypsa, Inc. (n.d.Ges.d. Staates Delaware) Ionen bindende Zusammensetzung
ITME20040015A1 (it) * 2004-12-07 2005-03-07 Vincenzo Savica Chewing gum, caramelle gommose, pastiglie, compresse a lento rilascio di chelanti fosfato e/o fosforo salivare e capsule a lento rilascio di chelanti fosfato e/o fosforo a livello gastroenterico.
US20070172472A1 (en) * 2005-06-23 2007-07-26 Asha Nayak Methods and Systems for Treating Injured Cardiac Tissue
US8932648B2 (en) * 2006-01-30 2015-01-13 Globoasia, Llc Method of selecting phosphate binder and its uses thereof
US20090162311A1 (en) 2006-06-16 2009-06-25 Masahiko Yamamori Agent for Prevention and/or Treatment of Glomerulopathy
EP2050456A4 (de) * 2006-08-09 2013-01-23 Mitsubishi Tanabe Pharma Corp Tablette
ES2573636T3 (es) * 2006-10-25 2016-06-09 Wisconsin Alumni Research Foundation Métodos para reducir la absorción de fosfato empleando un anticuerpo anti-Npt2B
CA2667613A1 (en) * 2006-10-26 2008-06-05 Wisconsin Alumni Research Foundation Methods for reducing phosphate absorption
JP5487379B2 (ja) * 2008-03-19 2014-05-07 森下仁丹株式会社 血中リン濃度上昇抑制剤
CN104258829B (zh) * 2014-09-24 2016-08-31 珠海健帆生物科技股份有限公司 血磷吸附剂及其制备方法、用于血液灌流的吸附柱
CN106366311B (zh) * 2015-07-23 2019-08-13 山东诚创医药技术开发有限公司 一种考来替兰的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56150017A (en) * 1980-04-22 1981-11-20 Mitsubishi Petrochem Co Ltd Cholesteril lowering agent
JPS57142920A (en) * 1981-03-02 1982-09-03 Mitsubishi Petrochem Co Ltd Cholesterol depressant
EP0098884B1 (de) * 1982-01-18 1986-07-23 Mitsubishi Petrochemical Co., Ltd. Heilmittel zum absenken cholesterolspiegels
JPS60209523A (ja) * 1984-04-03 1985-10-22 Mitsubishi Petrochem Co Ltd コレステロ−ル低下剤
US5380522A (en) * 1992-08-11 1995-01-10 Day; Charles E. Method for treatment of irritable bowel syndrome
AU6818894A (en) * 1993-05-20 1994-12-20 Geltex Pharmaceuticals, Inc. Process for adjusting ion concentration in a patient and compositions therefor
CA2129079C (en) * 1993-08-03 2006-01-17 Tatsuo Nomura Orally administrable cholesterol lowering agent
US5496545A (en) * 1993-08-11 1996-03-05 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
WO1996021454A1 (en) * 1995-01-12 1996-07-18 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration

Also Published As

Publication number Publication date
KR100561784B1 (ko) 2006-06-21
DE69705877T2 (de) 2002-06-06
US5980881A (en) 1999-11-09
ES2162658T3 (es) 2002-01-01
CA2199194C (en) 2005-12-27
TW528597B (en) 2003-04-21
CA2199194A1 (en) 1997-09-05
CN1080121C (zh) 2002-03-06
EP0793960A1 (de) 1997-09-10
KR970064610A (ko) 1997-10-13
EP0793960B1 (de) 2001-08-01
CN1169285A (zh) 1998-01-07

Similar Documents

Publication Publication Date Title
DE69705877T2 (de) Verwendung von Anionenaustauscherharzen zur Herstellung eines Arzneimittels zur Behandlung der Hyperphosphatemie
DE69534002D1 (de) Verwendung von Phosphatidylserinen zur Herstellung eines Arzneimittels zur Verbesserung der Gehirntätigkeit
DE69736183D1 (de) Verwendung von topiramat oder derivate davon zur herstellung eines arzneimittels zur behandlung von manisch-depressiven bipolaren störungen
DE59501599D1 (de) Verfahren zur Herstellung von Propandiol-1,2
DE69435330D1 (de) Verwendung von Botulinumtoxin Typ B zur Herstellung eines Medikaments zur Behandlung von Muskelkrämpfen
ATE248599T1 (de) Verwendung von xenon zur herstellung einer pharmazeutischen zusammensetzung zur behandlung von neurovergiftungen
DE69310065D1 (de) Verwendung von 2-(3,4-Dimethoxycinnamoyl)aminobenzoesäure zur Herstellung eines Arzeimittels zur Behandlung der Restenose
DE69022249D1 (de) Knochenwachsapplikator zur Behandlung von Knochengewebe.
DE69307509D1 (de) Vorrichtung zur behandlung von herzfehlern
DE69109560D1 (de) Fungizide Zusammensetzung zur Behandlung von Saatgut.
ATA76995A (de) Stabiles präparat zur behandlung von blutgerinnungsstörungen
DE69010251D1 (de) Dentale Einheit zur Behandlung eines Wurzelkanals.
DE69534190D1 (de) Verfahren zur Herstellung von 1,2-Benzisothiazol-3-onen
DE69910202D1 (de) EGR-1 zur Herstellung eines Medikamentes zur Behandlung von Wunden
DE69513110T2 (de) Verfahren zur Herstellung von exotherm reagierenden Zusammensetzungen
DE59200799D1 (de) Verfahren zur Herstellung von mehrkernigen aromatischen Polyaminen.
DE59200828D1 (de) Verfahren zur Herstellung von mehrkernigen aromatischen Polyaminen.
DE69637449D1 (de) Verwendung von alpha-hydroxysäuren zur herstellung eines arzneimittels für die behandlung von entzündungen
DE69423577T2 (de) Verwendung von Oenothein B zur Herstellung eines Medikaments zur Behandlung der durch Hyperandrogenität bedingte Störungen.
DE69313261T2 (de) Verwendung von LACTOFERRIN zur Herstellung eines THERAPEUTISCHEN MITTELS zur Behandlung von RHEUMATISMUS
DE59704933D1 (de) Verwendung von PHMB zur Behandlung von Tumorerkrankungen
DE69738320D1 (de) Verwendung von pyrolidin-derivaten zur herstellung von arzneimitteln zur behandlung von drogenmissbrauch
DE59501060D1 (de) Verfahren zur Herstellung von 2,5-Dihydrofuran
DE58900532D1 (de) Verfahren zur herstellung von bifunktionellen anionenaustauschharzen, neue bifunktionelle anionenaustauschharze und ihre verwendung.
DE68905657D1 (de) Verwendung von arginin-aspartat zur herstellung eines arzneimittels zur behandlung gewisser gedaechtnisstoerungen.

Legal Events

Date Code Title Description
8332 No legal effect for de
8370 Indication of lapse of patent is to be deleted
8364 No opposition during term of opposition